Liquid-vapour pressure reservoir for medication infusion pump

Abstract: A pressure reservoir (14) is provided for use with an implantable medication infusion pump (10) to maintain a selected medication (17) in liquid form within a pump housing (16) under a substantially constant pressure. The pressure reservoir (14) comprises a hollow structural enclosure having at least one flexible resilient wall and is adapted to be filled with a selected quantity of a pressure fluid (17), such as a selected fluorocarbon in a liquid-vapour state, prior to mounting the reservoir (14) as a structural unit in the infusion pump housing (16). Within the pump housing (16), the flexible reservoir wall defines one side of a medication chamber (14), with the pressure fluid (17) undergoing an appropriate change of state to expand or contract the reservoir in order to maintain the medication (17) under a substantially constant pressure.

Description: This invention relates generally to medication infusion pumps of the type for implantation directly into the body of a patient and for programmed operation to deliver medication to the patient, and more particularly to an improved and simplified fluid pressure reservoir for maintaining a supply of a selected medication under controlled pressure conditions in an implantable infusion pump. An infusion device comprising the features of the preamble of Claim 1 is disclosed in WO-A-83/02063. Medication infusion pumps are generally known in the art for use in delivering a selected medication to a patient in a scheduled or preprogrammed manner. In recent years, such infusion pumps have been developed in compact form adapted for direct implantation into the body of a patient, to deliver a specific medication such as insulin to the patient in discrete doses over an extended time period. An implanted infusion pump of this general type includes an internal medication chamber for receiving and storing a supply of the selected medication in liquid form, with the medication being subjected to a predetermined storage pressure to ensure accurate and repeatable delivery conditions through the use of a miniature pump and associated programmed control means. In many cases, the storage pressure is maintained at less than ambient body pressure to prevent undesired leakage of the medication from the medication chamber into the body of the patient, and thereby positively to prevent accidental overdose during certain failure modes. One illustrative example of an implanted medication infusion pump of this general type is shown in US Patent No. 4573994. In the past, the medication within the pump medication chamber has been subjected to the desired storage pressure by forming at least a portion of the medication chamber as a movable wall or diaphram shared with a pressure reservoir charged with a pressure fluid. Such a device is disclosed in WO 83/02063, in which the pressure fluid has comprised a selected fluid in a liquid-vapour state, such as a selected fluorocarbon, wherein the pressure fluid undergoes liquid-vapour change of state at normal body temperature to expand or contract appropriately the pressure reservoir in an manner acting through the diaphram to maintain the medication chamber under substantially constant pressure conditions. As the medication chamber is filled, the pressure fluid undergoes significant state change to the liquid phase to reduce the volumetric size of the pressure reservoir. Conversely, as the medication is delivered in doses to the patient, the pressure fluid progressively undergoes state change to the vapour phase to maintain the medication under substantially constant pressure. Freon 113 has been used to maintain the medication at a slight negative or subambient pressure in response to normal patient body temperature and altitudinal variations up to about 8,500 feet (25.91m) above sea level. While such implantable infusion pumps constitute a major step forward in the reliable and convenient administration of certain medications, some design aspects of such pumps have contributed to a relatively complex and costly pump construction. For example, in the device of WO 83/02063, referenced above, it is taught to construct the movable wall or barrier separating the pressure reservoir from the medication chamber from a metal, or metal coated elastomer material to permit leak-free attachment to the pump housing which has also been constructed from a biocompatible metal material, particularly such as titanium or titanium alloy. US 4857055 discloses a device for squeezing medication from a chamber by compressing the chamber with two Freon-filled bladders. The device is not intended for implanting into the human body, and will not operate necessary if either of the bladders is removed. Current implantable pumps have used bellows devices formed from annular metal rings which are interconnected by a series of thin circular welds requiring an extremely high degree of precision and costly manufacturing equipment. Moreover, in use, such metal bellows structures have encountered occasional and highly undesirable fatigue failures. Further, the bellows devices tend to occupy a substantial portion of the internal pump housing volume, resulting in significant limitations in medication capacity or otherwise resulting in a pump housing of relatively large size. There exists, therefore, a significant need for further improvements in and to implantable medication infusion pumps, particularly with respect to improvements in the design and operational reliability of the movable wall or barrier separating the medication from a liquid-vapour pressure fluid within a pressure reservoir. The present invention seeks to fulfil these needs. According to the invention, there is provided a medication infusion device comprising: a housing including a medication chamber for receiving a supply of a selected medication; delivering means within the housing for delivering the medication from the medication chamber to a patient; and a pressure reservoir containing a selected liquid-vapour pressure fluid, the pressure reservoir being located within the housing and defining a movable wall exposed to the medication chamber, the pressure fluid being adapted to undergo sufficient liquid-vapour phase change to vary the volumetric size of the pressure reservoir in response to the quantity of the medication within the medication chamber to maintain the medication under a predetermined and substantially constant pressure, the housing being hemectically sealed to permit direct implantation into the body of the patient, characterised in that the pressure reservoir is an independent expansible structural enclosure, preferably in the form of a bag. The invention, in its broadest sense, encompasses the pressure reservoir per se as defined above. Thus, in accordance with the invention, a medication infusion pump adapted for implantation into a body of a patient can be improved and simplified yet highly reliable pressure reservoir for maintaining a selected medication under substantially constant pressure conditions. The pressure reservoir is preferably adapted to be filled or charged with a selected pressure fluid prior to mounting as a structural unit into the housing of the infusion pump. At least a portion of the pressure reservoir preferably comprises a flexible and resilient wall shared with the medication chamber within the pump housing. The pressure fluid is selected to provide a liquid-vapour state at normal patient body temperature and within a normal altitude range, such that the reservoir expands and contracts as the medication chamber is respectively emptied or filled to subject medication within the medication chamber to substantially constant pressure conditions. In a preferred form, the pressure reservoir comprises a sack or bag having an appropriate disc-shaped or other suitable configuration for mounting to or into the infusion pump housing. The reservoir bag is constructed from a flexible, impermeable, medication and pressure fluid compatible material. In the preferred embodiment, Halar film is chosen for its compatibility with and relative impermeability to a fluorocarbon pressure fluid such as Freon 113 as well as to medications. The reservoir bag is filled with a selected quantity of the pressure fluid and then appropriately sealed for subsequent mounting as a unit into the pump housing. Adhesive means or other suitable structural means may be provided within the pump housing to hold the reservoir bag in place and/or to prevent the reservoir bag from obstructing medication flow to a discharge pump for administration to the patient. In another preferred form, the pressure reservoir can be defined by a relatively rigid plastic base disc adapted for connection to a flexible diaphragm to receive and store the pressure fluid. Once again, Halar film or a similar material is preferred for both the base disc and diaphragm. The base disc is adapted for secure and fixed mounting to or within the pump housing, such as by use of an adhesive or the like. The reservoir constructed in this way is adapted for filling with the pressure fluid prior to installation as a unit or into the pump housing. To still another preferred form, the pressure reservoir is constructed as a semicircular shape to receive and store the pressure fluid. The filled bag is adapted for mounting into a pump housing with one side of the bag co-operating with the housing to define a similarly shaped medication chamber. With this geometry, the pressure reservoir and medication can be located at one side of a relatively thin disc-shaped pump housing, with a miniature pump and associated control means located in the opposite semicircular side of the pump housing. With the device according to the invention, a selected pressure in the medication chamber contained in the implantable liquid medication infusion pump is maintained. This is achieved by filling a structural enclosure having at least one flexible wall with a selected liquid-vapour pressure fluid; and installing said structural enclosure within the medication chamber, said pressure fluid being adapted to undergo sufficient liquid-vapour phase change for varying the volumetric size of said structural enclosure in response to the quantity of the medication within the medication chamber to maintain the medication under a predetermined and substantially constant pressure. The invention may be carried into practice in various ways and some embodiments will now be described by way of example with reference to the accompanying drawings, in which: Figure 1 is a perspective view of an implantable medication infusion pump adapted to include a liquid-vapour pressure reservoir in in accordance with the invention; Figure 2 is an enlarged vertical section of the pump of Figure 1, Figure 3 is a fragmentary perspective view showing a preferred liquid-vapour pressure reservoir construction; Figure 4 is an enlarged vertical section similar to Figure 2, showing an infusion pump with a liquid-vapour pressure reservoir of an alternative preferred geometry; Figure 5 is an exploded perspective view illustrating the assembly of the reservoir of Figure 4; Figure 6 is an enlarged fragmentary vertical section of a portion of the pressure reservoir of Figure 4, illustrating operation of the reservoir during pump operation to deliver medication to a patient; Figure 7 is a top plan view of another alternative preferred form of the liquid-vapour pressure reservoir in accordance with the present invention; Figure 8 is an enlarged transverse vertical section taken generally on the line 8-8 of Figure 7; Figure 9 is a top plan view of an infusion pump adapted for use with the pressure reservoir of Figures 7 and 8, with an upper portion of the pump housing removed to illustrate the arrangement of pump components; and Figure 10 is an enlarged vertical section taken generally on the line 10-10 of Figure 9. As shown in the exemplary drawings, an implantable medication infusion pump referred to generally in Figures 1 and 2 by reference to numeral 10 is provided for use in administering a selected medication to a patient in a controlled, preprogrammed manner. The infusion pump 10 receives and stores a quantity of the selected medication within an internal medication chamber 12 (Figure 2), wherein the medication is subjected to predetermined and substantially constant pressure through the use of an improved and simplified reservoir 14. The illustrative medication infusion pump 10 comprises a small and substantially self-contained unit for direct implantation into the body of a patient. The pump 10 comprises a hermetically sealed pump housing 16 made from a biocompatible material such as titanium or titanium alloy. The pump housing 16 defines the internal medication chamber 12 for receiving and storing the supply of the selected medication 17 in liquid form, such as insulin for a diabetic patient. The pump housing 16 further encases a miniature dispensing pump 18 and associated electronic control circuitry 20 in combination with a battery 22 for periodically operating the pump 18 to deliver medication via an appropriate catheter 24 or the like. The control circuitry is suitably preprogrammed to deliver the medication in accordance with individual patient need. An inlet or refill fitting 26 on the pump housing 16 is adapted to receive a hypodermic needle (not shown) to permit percutaneous refilling of the medication chamber 12 without requiring surgical access to the infusion pump 10. For a more detailed description of the overall pumps of this general type, see US Patent Nos. 4373527, and 4573994. The infusion pump 10 includes the variable volume pressure reservoir 14 mounted within the pump housing 16 with at least one wall of the pressure reservoir 14 exposed to and thereby defining at least a portion of the medication chamber 12. More particularly, the pressure reservoir 14 contains a selected pressure medication chamber 12 in accordance with the quantity of medication therein to maintain the medication under substantially constant pressure conditions. A preferred pressure fluid comprises a fluorocarbon which has a substantially linear pressure characteristic as it changes from liquid to vapour state and vice versa at normal human body temperature and at a normal range of altitudes. A preferred pressure fluid is Freon 113 which assumes a liquid-vapour state at normal body temperature and at altitude variations up to about 8,500 feet (25.91m) above sea level to exert a slightly negative and substantially constant pressure of approximately -2.5 (1.76kg/mm²) to -4.0 psi (2.81kg/mm²) on the medication chamber 12. This slight negative pressure beneficially confines the medication against undesired leakage from the pump housing 16 into the body of the patient in the event of a crack or other damage to the pump housing 16. Alternatively, other liquid-vapour pressure fluids are known in the art for applying other specific pressures to the medication, such as a positive pressure which may be required for some implantable pump design. Such an application will be discussed below. In any event, in accordance with the primary aspect of the present invention, the pressure reservoir 14 has a simplified and improved construction for achieving significant reductions in the pump complexity and cost, as well as significant improvements in pump reliability. In addition, the improved pressure reservoir provided by the present invention permits the implantable pump 10 to have an increased medication-containing capacity without increasing pump size, or alternatively to have a decreased overall size without reducing pump medication-containing capacity. More specifically, with reference to Figures 2 and 3, the pressure reservoir 14 comprises a flexible and expansible sack or bag 28 shown with a generally disc-shaped configuration and defined by circular sheets 29 and 30 of a plastic film material connected about their peripheries by heat sealing or the like to form a hollow interior. This flexible bag 28 is formed as a structural unit separate from the remaining components of the infusion pump 10, and is desirably filled with the pressure fluid 27 prior to the bag 28 being located in the pump housing 16. A preferred material used to construct the bag 28 is ethylene-chlorotrifluoroethylene copolymer (ECTFE), which is sold under the name HALAR by Ausimont USA of Morristown, New Jersey. In this regard, Halar film is especially suited for use in the environment of implantable infusion pumps due to its relatively high compatibility with and impermeability to fluorocarbon pressure fluids, such as Freon 113, as well as to its compatibility with and impermeability to medications. The pressure reservoir 14 constructed in this way comprises a flexible yet self-contained structural unit adapted for relatively simple and cost-efficient mounting into the pump housing 16, such as by placement into a lower shell-shaped housing half 31 prior to assembly of the lower half 31 with an upper shell-shaped housing half 32 having the pump 18, the circuitry 20 and the battery 22 installed therein. An adhesive 34 may be used to seat and retain the lower sheet 29 of the bag 28 against the lower housing half 31, such that the opposite or upper sheet 30 of the bag defines a movable wall at one side of the medication chamber 12. Short spacer posts 36 may be provided around an intake port 38 leading to the miniature pump 18 to prevent any portion of the bag 28 from obstructing medication flow from the chamber 12 to the pump for administration to the patient. In operation, the liquid-vapour pressure fluid within the pressure reservoir 14 expands and contracts the reservoir volume in a manner inversely varying the volume of the medication chamber 12. In particular, as the medication chamber 12 is filled with medication, the pressure fluid undergoes the appropriate change of state to the liquid phase to the extent necessary to accommodate the medication yet maintain the medication under a substantially constant pressure. As the medication is dispensed to the patient in individual doses, the pressure fluid undergoes a gradual state change to the vapour phase with a corresponding expansion of the pressure reservoir sufficient to maintain the remaining medication in the chamber 12 under a substantially constant pressure. An alternative preferred form of the invention is shown in Figures 4 to 6, in which a modified pressure reservoir 114 is provided to maintain the medication 17 within the infusion pump 10 under substantially constant pressure conditions. In this embodiment, the pressure reservoir 114 is constructed from a relatively more rigid lower base disc 129 formed by moulding to have a generally annular shape and upturned circular margins at its inner and outer edges. These circular margins are secured by heat sealing or the like to the inner and outer edges of an upper flexible diaphragm 130 of annular shape so that the base disc 129 and the diaphragm 130 together define a hollow annular interior for receiving and storing a selected quantity of the pressure fluid 27. Alternatively, if desired, the base disc 129 and the attached diaphragm 130 may be formed in a circular or any other selected shape. The reservoir 114 of Figures 4 to 6 is adapted for filling with the pressure fluid before installation into the pump housing, in generally the same manner and sequence as described with respect to Figures 2 and 3. When installed, the base disc 129 can be seated quickly and easily into a lower housing half 31 by means of an adhesive and/or by a mating snap or press fit mounting. The preferred material used to form the base disc 129 and the diaphragm 130 again comprises a Halar film or some other material having similar properties suitable for use with the selected pressure fluid. In use, the diaphragm 130 is displaced back and forth as the adjacent medication chamber 12 is filled and emptied, as shown in Figure 6, so that the medication within the chamber 12 is maintained under substantially constant pressure. The embodiment of Figures 4 to 6 could easily be varied to exclude the base disc 129, and use the bottom of the lower housing half 31 instead. In this case, the diaphragm 130 would be attached, typically by the use of adhesive, directly to the sides of the lower housing half 31. Figures 7 to 10 show another preferred embodiment of the invention, in which a pressure reservoir 214 is formed as a flexible bag or sack 228 with a generally semicircular shape. In this version of the invention, similarly to the embodiment of Figures 2 and 3, the flexible bag 228 is preferably formed from interconnected sheets of Halar film or the like and is adapted to be filled with the selected pressure fluid 27 before installation into a modified pump housing 216. As shown in Figures 9 and 10, the flexible bag 228 is mounted as a structural unit into a generally semicircular chamber 40 at one side of the housing 216 which has generally circular disc shape. With this geometry, the pump housing 216 co-operates with one side of the bag 228 to define a semicircular medication chamber 212. A centrally positioned inlet fitting 226 on the pump housing 216 permits the medication chamber 212 to be filled with the selected medication 17, and a dispensing pump 218 is provided for delivering the medication in doses from the chamber 212 to the patient. The pump 218 is controlled by miniature control circuitry and a battery power source referred to generally in Figures 9 and 10 by the reference numeral 41 and positioned in another generally semicircular chamber 42 disposed opposite to the reservoir 214. The pump configuration shown in Figures 9 and 10 thus includes the reservoir 214 and the associated medication chamber 212 in a noncircular shape, in contrast with the traditional circular shape, reservoirs and chambers defined in the art through the use of metal bellows devices. Moreover, the reservoir 214 and the medication chamber 212 are generally disposed in a common plane with the other main components of the infusion pump. This arrangement provides a substantial optimisation of the available pump housing interior volume and thereby permits the overall pump size to be significantly reduced without sacrificing medication-containing capacity. Alternatively, the volumetric capacity of the medication chamber 212 can be significantly increased relative to prior pumps of similar size. As mentioned above, the flexible bag type pressure reservoir could also be used with a positive pressure pump. Such pumps maintain fluid in a medication chamber at a positive pressure ranging up to, for example, 10 psi (7kg/mm²). Referring again to Figure 2, a positive pressure pump could have the medication chamber 12, the pressure reservoir 14, the inlet or refill fitting 26 as shown in Figure 1. However, such positive pressure pumps in their simplest form include only a flow restrictor between the reservoir and the catheter. In such a pump, reference numeral 18 in Figure 1 would refer to a flow restrictor, which is typically a capillary tube. In addition, such simple pumps do not have the circuitry 20 and the battery 22 installed therein. A slightly more complex positive pressure pump would have a valve (not shown) in series with the flow restrictor, all at reference numeral 18. This type of pump would have the circuitry 20 and the battery 22 installed therein, and could be externally controlled. This type of pump would operate at a fixed flow rate whenever the valve was open. A still more complex positive pressure pump would use two valves with an accumulator therebetween, as well as the circuitry 20 and the battery 22. This type of pump would be externally controlled by opening first the valve between the medication reservoir and the accumulator to fill the accumulator. This valve would be closed, and the valve between the accumulator and the catheter would be opened to allow the accumulator to pump out the accumulated medication.

Claims: A medication infusion device (10) comprising: a housing (16) including a medication chamber (12) for receiving a supply of a selected medication (17); delivering means (18) within the housing (16) for delivering the medication (17) from the medication chamber (12) to a patient; and a pressure reservoir (14) containing a selected liquid-vapour pressure fluid (27), the pressure reservoir (14) being located within the housing (16) and defining a movable wall exposed to the medication chamber (12), the pressure fluid (17) being adapted to undergo sufficient liquid-vapour phase change to vary the volumetric size of the pressure reservoir (14) in response to the quantity of the medication (17) within the medication chamber (12) to maintain the medication (17) under a predetermined and substantially constant pressure, the housing (16) being hermetically sealed to permit direct implantation into the body of the patient, characterised in that the pressure reservoir (14) is an independent expansible structural enclosure, preferably in the form of a bag. A device as claimed in Claim 1, characterised in that the movable wall of the pressure reservoir (14) is formed from a flexible, impermeable, medication and pressure fluid compatible material. A device as claimed in Claim 1 or Claim 2, characterised in that the pressure reservoir (14) is an expansible bag comprising a pair of plastic film sheets (29,30) interconnected about the peripheries to define a hollow bag (28) interior for receiving the pressure fluid (17). A device as claimed in Claim 1 or Claim 2, characterised in that the pressure reservoir (14) comprises a pillow-shaped member (214) having two sides made of a flexible material sealed about their periphery to enclose the selected liquid-vapour pressure fluid (17). A device as claimed in any preceding Claim, characterised in that the movable wall and/or the structural enclosure (14) is formed from Halar film material. A device as claimed in any preceding Claim, characterised in that the delivery means includes an intake port (38) in communication with the medication chamber (12), and means (36) for preventing the pressure reservoir from obstructing the intake port (38). A device as claimed in any preceding Claim, characterised in that the pressure fluid (17) is selected to maintain the medication chamber under a pressure less than atmospheric pressure , and the delivery means comprises a pump (18). A device as claimed in any preceding Claim, characterised in that the pressure fluid (17) comprises a fluorocarbon, preferably Freon 113. A device as claimed in any of Claims 1 to 6, characterised in that the pressure fluid (17) is selected to maintain the medication chamber (12) under a pressure greater than atmospheric pressure. A device as claimed in any preceding Claim, characterised by means (34) for securing the pressure reservoir within the housing (16).

Inventors: LORD PETER C, MANN ALFRED E, LORD, PETER C., MANN, ALFRED E.
Applicants: MINIMED INC DOING BUSINESS AS, MINIMED INC., DOING BUSINESS AS MINIMED TECHNOLOGIES
Application year: 1991
Main classification: A61M5
IPC codes: A61M1, A61M5, A61M37